Mark Paternoster
VP, Asset Lead, Zelenectide Pevedotin Bt8009 @Bicycle Therapeutics
Cambridge, GB
EMAILS
MOBILE NUMBERS
+91 *********19
Signup · Get unlimited contacts
WORK HISTORY
Sep 2024 — Present
VP, Asset Lead, Zelenectide Pevedotin Bt8009 @Bicycle Therapeutics
View department →
Cambridge, GB
EDUCATION
N/A
University of Surrey
MSc, Pharmaceutical Medicine
N/A
University of Kent
PhD, Microbiology
N/A
University of Bristol
BSc, Microbiology
ABOUT MARK PATERNOSTER
An impactful R&D Leader and Product Champion with broad operational and strategic knowledge, adept at managing ambiguity and change in a fast-paced environment. Fosters productive connections between R&D groups and with internal and alliance business stakeholders to deliver new medicines with ambitious target product profiles in therapeutic areas of high unmet need, through accountable high-performing teams.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.